Products
Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.
All Products (882)
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Linezolid |
Antibiotic (Febrile Neutropenia) | Both (Solid & Hematologic) | ||
|
Molecule
Linezolid
Therapeutic Category
Supportive Care (Anti-Infective)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antibiotic (Febrile Neutropenia) |
||||
Lipegfilgrastim |
G-CSF / GM-CSF Analogue | Both (Solid & Hematologic) | ||
|
Molecule
Lipegfilgrastim
Therapeutic Category
Supportive Care (Growth Factor)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
G-CSF / GM-CSF Analogue |
||||
Liposomal Cytarabine |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Liposomal Cytarabine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Liposomal Daunorubicin |
Anthracycline / Anthracenedione | Both (Solid & Hematologic) | ||
|
Molecule
Liposomal Daunorubicin
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
||||
Liposomal Doxorubicin (Pegylated) |
Anthracycline / Anthracenedione | Both (Solid & Hematologic) | ||
|
Molecule
Liposomal Doxorubicin (Pegylated)
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
||||
Liposomal Irinotecan |
Topoisomerase Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Liposomal Irinotecan
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
||||
Liposomal Vincristine |
Antimicrotubule Agent | Both (Solid & Hematologic) | ||
|
Molecule
Liposomal Vincristine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimicrotubule Agent |
||||
Lobaplatin |
Platinum Compound | Solid Tumour | ||
|
Molecule
Lobaplatin
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
Platinum Compound |
||||
Lomustine |
Alkylating Agent | Both (Solid & Hematologic) | ||
|
Molecule
Lomustine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
||||
Lorazepam (Onc Adjunct) |
Corticosteroid / Antipsychotic / Antidopaminergic | Both (Solid & Hematologic) | ||
|
Molecule
Lorazepam (Onc Adjunct)
Therapeutic Category
Supportive Care (Antiemetic/Adjunct)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Corticosteroid / Antipsychotic / Antidopaminergic |
||||
Lurbinectedin |
Enzyme / Oncolytic Virus / Miscellaneous Cytotoxic | Both (Solid & Hematologic) | ||
|
Molecule
Lurbinectedin
Therapeutic Category
Cytotoxic Chemotherapy / Miscellaneous
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Enzyme / Oncolytic Virus / Miscellaneous Cytotoxic |
||||
Lurtotecan |
Topoisomerase Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Lurtotecan
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
||||
LinezolidSupportive Care (Anti-Infective) |
|
|
Therapeutic Category
Supportive Care (Anti-Infective)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antibiotic (Febrile Neutropenia) |
|
LipegfilgrastimSupportive Care (Growth Factor) |
|
|
Therapeutic Category
Supportive Care (Growth Factor)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
G-CSF / GM-CSF Analogue |
|
Liposomal CytarabineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
Liposomal DaunorubicinCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
|
Liposomal Doxorubicin (Pegylated)Cytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
|
Liposomal IrinotecanCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
|
Liposomal VincristineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimicrotubule Agent |
|
LobaplatinCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
Platinum Compound |
|
LomustineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
|
Lorazepam (Onc Adjunct)Supportive Care (Antiemetic/Adjunct) |
|
|
Therapeutic Category
Supportive Care (Antiemetic/Adjunct)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Corticosteroid / Antipsychotic / Antidopaminergic |
|
LurbinectedinCytotoxic Chemotherapy / Miscellaneous |
|
|
Therapeutic Category
Cytotoxic Chemotherapy / Miscellaneous
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Enzyme / Oncolytic Virus / Miscellaneous Cytotoxic |
|
LurtotecanCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
|